ArticleFrontiers in oncology2022

Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer.

Satoshi Wasamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.